Pro-Dex, Inc.

PDEX ·Healthcare, Medical Devices, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Assets
Cash & Equivalents $8.2M $419.0K $2.6M $2.9M $849.0K $3.7M $6.4M $7.7M
Accounts Receivable $21.2M $16.4M $13.9M $10.0M $15.4M $10.9M $5.2M $4.1M
Inventory $21.5M $22.2M $15.3M $16.2M $12.7M $8.4M $8.2M $6.2M
Total Current Assets $53.2M $47.3M $36.6M $31.0M $31.2M $25.0M $22.7M $20.8M
Property, Plant & Equipment $5.4M $5.2M $5.0M $5.1M $4.8M $3.8M $2.7M $2.7M
Goodwill $6.5M — — — — — — —
Intangible Assets (Excl. Goodwill) $686.0K $26.0K $54.0K $81.0K $118.0K $186.0K $162.0K $129.0K
Total Assets $74.5M $61.2M $52.5M $51.8M $51.9M $43.3M $39.1M $25.5M
Liabilities
Accounts Payable $4.3M $4.6M $4.5M $2.3M $3.8M $2.3M $2.0M $2.0M
Total Current Liabilities $13.0M $14.6M $12.9M $9.7M $11.4M $6.3M $5.2M $4.3M
Long-Term Debt $17.5M $15.4M $12.0M $12.8M $13.6M $12.8M $4.0M $4.6M
Total Liabilities $26.9M $24.6M $21.6M $20.2M $23.6M $20.2M $12.1M $3.3M
Stockholders' Equity
Retained Earnings $47.6M $35.9M $27.0M $24.8M $21.7M $15.3M $9.9M $1.7M
Total Stockholders' Equity $47.6M $36.6M $30.9M $31.6M $25.4M $21.1M $19.1M $17.0M
← Newer Page 1 of 2 Older →